FindTrial
Sign In

To assess the safety and efficacy of a corneal strengthening procedure combined with refractive error correction in patients with weak corneas.

Topography guided photorefractive keratectomy with accelerated collagen crosslinking (KXL) in the management of mild to moderate keratoconus.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/10/006263
Enrollment
20
Registered
2015-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- mild to moderate keratoconus

Interventions

Intervention1: Corneal collagen cross-linking with Riboflavin(KXL): Patients with mild to moderate keratoconus will undergo KXL along with Photorefractive keratectomy. Control Intervention1: pre-op an

Sponsors

Nethradhama Superspeciality Eye Hospital Banaglore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Patients with mild to moderate keratoconus. • Patients with pachymetry more than 400 microns

Exclusion criteria

Exclusion criteria: A. Exclusion criteria: • Patients with severe keratoconus • Patients with pachymetry less than 400 microns • Patients with glaucoma or retinal causes of low vision.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy and safety of topography guided photorefractive keratectomy with accelerated collagen crosslinking (KXL) in the management of mild to moderate keratoconus.Timepoint: To evaluate the efficacy and safety of topography guided photorefractive keratectomy with accelerated collagen crosslinking (KXL) in the management of mild to moderate keratoconus.—

Secondary

MeasureTime frame
To evaluate the satisfaction of visual outcomeTimepoint: day 30 and day 90 post-operatively—

Countries

India

Contacts

Public ContactDr Vipul Bhandari

NETHRADHAMA SUPERSPECIALITY EYE HOSPITAL

drvipulbhandari@gmail.com9901815342

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026